Back

Genotype-dependent NT-proBNP, cardiac remodeling and pharmacokinetic marker dynamics after acute decompensation in heart failure: insights from the BeLove study

1 September 2025 (09:15 - 10:00)
Organised by: Logo
Congress Presentation Part of: Biomarkers and prognosis in acute heart failure Pathophysiology and Mechanisms ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Ms Emily Ghanbari

German Heart Centre Berlin, Berlin (Germany)

7 More presentations in this session

Presentation thumbnail
Association between high serum uric acid and poor outcomes in patients with acute heart failure.
Doctor F. Qorina (Oxford, GB)
Abstract Slides Video
Presentation thumbnail
Diagnostic and prognostic performance of insulin-like growth factor-binding protein 7 in patients with acute dyspnea in the emergency department
Ms C. Popescu (Basel, CH)
Abstract Slides Video
Presentation thumbnail
The role of exhaled breath acetone and BNP in predicting outcomes in advanced heart failure
Doctor D. Motta Da Costa Dan (Vitoria, BR)
Abstract Slides Video
Presentation thumbnail
Admission natriuresis as a predictor of outcomes in acute decompensated heart failure
Mr J. Iroulart (Buenos Aires, AR)
Abstract Slides Video
Presentation thumbnail
Resolution of systemic inflammation in patients with recently decompensated heart failure with reduced ejection fraction with and without interleukin-1 blockade by anakinra
Doctor A. Abbate (Charlottesville, US)
Abstract Slides Video

Access the full session

Session thumbnail
Biomarkers and prognosis in acute heart failure

The Event

Event poster

ESC Congress 2025

1 September 2025 09:15 CET
You may be interested in
thumbnail
Congress Presentation
Early increase and subsequent decrease in mature BNP and early decrease and continued decrease in proBNP after sacubitril/valsartan may relate to left ventricular reverse remodeling in heart failure
thumbnail
Congress Session
Basic and Translational Late-Breaking Science session
thumbnail
Congress Session
Biomarkers definning pathophysiology and prognosis

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources